Major trial tests new drug cocktail to wipe out parasitic diseases in island communities
NCT ID NCT07159373
Summary
This large study aims to see if a new combination of existing drugs (moxidectin, diethylcarbamazine, and albendazole) is safe and effective for treating three parasitic diseases—lymphatic filariasis, scabies, and strongyloidiasis—in communities in Fiji where these infections are common. Researchers will compare this new combination to the current standard treatment. About 5,100 residents will receive three single doses of medication, one year apart, and be monitored for safety and whether the treatment clears the infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCABIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ministry of Health and Medical Services Fiji
Suva, Fiji
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.